logo

LUMO(Delisted)

Lumos Pharma·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 1
Bearish signal 2
Significant Revenue Decline
EPS Beats Expectation
Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About LUMO

Lumos Pharma, Inc.

A biopharmaceutical company that develops immunotherapeutic therapy for cancer

--
06/04/1999
11/11/2011
NASDAQ Stock Exchange
33
12-31
Common stock
4200 Marathon Blvd., Suite 200, Austin, Texas 78756
--
Lumos Pharma, Inc., founded in Delaware on June 4, 1999 as NewLink Genetics Corporation, is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapy products to improve treatment options for cancer patients. The company's products include biological and small molecule immunotherapy products. The Company's biological products are based on the Company's proprietary hyperacute immunotherapy technology, which is designed to stimulate the human immune system. The Company's small molecule products focus on breaking the tolerance of the cancer immune system by inhibiting the indoleamin- (2, 3) -plus dioxygenase pathway. The Company believes that the Company's immunotherapy technology has the potential to generate multiple products for the treatment of a wide range of tumor symptoms that can be treated alone or in combination with therapies.

Company Financials

EPS

LUMO has released its 2024 Q2 earnings. EPS was reported at -0.93, versus the expected -1.24, beating expectations. The chart below visualizes how LUMO has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

LUMO has released its 2024 Q3 earnings report, with revenue of 726.00K, reflecting a YoY change of 10271.43%, and net profit of -7.47M, showing a YoY change of 10.04%. The Sankey diagram below clearly presents LUMO's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime

No Data